Bone Biologics Corporation
07/24/2026 | Press release | Archived content
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 24, 2026 10:00 A.M. |
| Form: | S-3 | ||||||
|
|||||||
Bone Biologics Corporation published this content on July 24, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 27, 2026 at 10:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]